Research ArticleNuclear Oncology
Gallium-68 Chelate Imaging of Human Colon Carcinoma Xenografts Pretargeted with Bispecific Anti-CD44V6/Anti-Gallium Chelate Antibodies
Gabor Klivényi, Jochen Schuhmacher, Erik Patzelt, Harald Hauser, Ronald Matys, Marion Moock, Thomas Regiert and Wolfgang Maier-Borst
Journal of Nuclear Medicine October 1998, 39 (10) 1769-1776;
Gabor Klivényi
Jochen Schuhmacher
Erik Patzelt
Harald Hauser
Ronald Matys
Marion Moock
Thomas Regiert
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Gallium-68 Chelate Imaging of Human Colon Carcinoma Xenografts Pretargeted with Bispecific Anti-CD44V6/Anti-Gallium Chelate Antibodies
Gabor Klivényi, Jochen Schuhmacher, Erik Patzelt, Harald Hauser, Ronald Matys, Marion Moock, Thomas Regiert, Wolfgang Maier-Borst
Journal of Nuclear Medicine Oct 1998, 39 (10) 1769-1776;
Gallium-68 Chelate Imaging of Human Colon Carcinoma Xenografts Pretargeted with Bispecific Anti-CD44V6/Anti-Gallium Chelate Antibodies
Gabor Klivényi, Jochen Schuhmacher, Erik Patzelt, Harald Hauser, Ronald Matys, Marion Moock, Thomas Regiert, Wolfgang Maier-Borst
Journal of Nuclear Medicine Oct 1998, 39 (10) 1769-1776;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The Promise of Immuno-PET in Radioimmunotherapy
- Reagents and Methods for PET Using Bispecific Antibody Pretargeting and 68Ga-Radiolabeled Bivalent Hapten-Peptide-Chelate Conjugates
- In Vivo Evaluation of Pretargeted 64Cu for Tumor Imaging and Therapy
- Pretargeted Radioimmunotherapy of Cancer: Progress Step by Step
- A Universal Pretargeting System for Cancer Detection and Therapy Using Bispecific Antibody
- Molecular Advances in Pretargeting Radioimunotherapy with Bispecific Antibodies
- Immunoscintigraphy with Positron Emission Tomography: Gallium-68 Chelate Imaging of Breast Cancer Pretargeted with Bispecific Anti-MUC1/Anti-Ga Chelate Antibodies